Scott C. Wise
Geschäftsführer bei Molecular Imaging, Inc.
Profil
Scott C.
Wise is currently the Vice President-Operations at Molecular Imaging, Inc. Previously, he worked as the Senior Director-Biology at Deciphera Pharmaceuticals LLC, as well as a Principal at Pfizer Inc. and the National Cancer Institute.
He holds a graduate degree from the University of Toledo (Ohio).
Aktive Positionen von Scott C. Wise
| Unternehmen | Position | Beginn |
|---|---|---|
Molecular Imaging, Inc.
 Molecular Imaging, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Imaging, Inc. provides research services supported by extensive in vivo imaging capabilities. Its services include oncology pharmacology, immuno-oncology, imaging, radiation, and in vivo biodistribution. The company was founded by Wilbur R. Leopold, John Fleming, and Patrick McConville in 2003 and is headquartered in Ann Arbor, MI. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Scott C. Wise
| Unternehmen | Position | Ende |
|---|---|---|
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Ausbildung von Scott C. Wise
| University of Toledo (Ohio) | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Molecular Imaging, Inc.
Molecular Imaging, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Imaging, Inc. provides research services supported by extensive in vivo imaging capabilities. Its services include oncology pharmacology, immuno-oncology, imaging, radiation, and in vivo biodistribution. The company was founded by Wilbur R. Leopold, John Fleming, and Patrick McConville in 2003 and is headquartered in Ann Arbor, MI. | Commercial Services |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
